AGARWAL SUNIL 4
4 · Astria Therapeutics, Inc. · Filed Apr 9, 2024
Insider Transaction Report
Form 4
AGARWAL SUNIL
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-04-08+28,200→ 28,200 totalExercise: $11.40Exp: 2034-04-07→ Common Stock (28,200 underlying)
Footnotes (1)
- [F1]This option was granted on April 8, 2024 and is scheduled to vest as to one-third of the shares of common stock underlying the option on each anniversary of the grant date until the third anniversary of the grant date, subject to the director's continued service.